The collaboration will offer people an opportunity to learn about and potentially participate in a Phase III clinical trial within Walgreens pharmacies.
NACDS submitted the statement before Wednesday’s House Energy and Commerce Subcommittee on Oversight and Investigations and Senate Finance Committee hearings examining the impact of the Change Healthcare cyberattack.